World Brucellosis Market is Expected to Grow at a CAGR of Approximately 7.8% During The Forecast Period 2017-2023

Brucellosis Market

Market Research Future has a half-cooked research report on the global brucellosiss market. It will boost market at a strong CAGR of 7.8% during the forecast period 2017-2023

Brucellosis is a zoonotic infection caused by the species of Brucella bacteria. The bacteria is transmitted from animals to humans through infected food products, direct contact with an infected animal, or inhalation of aerosols. The disease is known by many names, including Mediterranean fever, Malta fever, gastric remittent fever, and undulant fever. Usually, humans are accidental hosts, but brucellosis still continues to remain a major health concern worldwide. Brucellosis is a has a high degree of morbidity in humans worldwide. According to WHO data about 500,000 cases of this disease are registered in the world every year.

Usually, Brucella abortus is associated with the disease in cattle and bison, Brucella suis with the disease in swine, and Brucella melitensis with the disease in sheep and goats. Under appropriate conditions, brucellosis can be caused in one species by a Brucella organism associated with other host species. Favorable government policies for research, and the presence of a large number of players in the global brucellosis market are the key factors driving the growth of the market during the forecast period. 

Sample Report Available at .

The brucellosiss is segmented on the basis of species, diagnosis, treatment and end-users.

On the basis of species, the market is segmented into Brucella suis, Brucella abortus, Brucella melitensis, Brucella canis and others

On the basis of diagnosis, market is segmented into serological tests, molecular techniques, bone marrow biopsy, X-rays, computerized tomography (CT), magnetic resonance imaging (MRI), cerebrospinal fluid culture, echocardiography and others. The serological tests is segmented into serum agglutination test, rose bengal test, lateral flow assay, compliment fixation test, coombs test, enzyme linked immuno sorbent assaym, and immunocapture-agglutination test (brucellacapt). The molecular techniques is segmented into Polymerase Chain Reaction (PCR), Loop- mediated isothermal amplification assay, Multiple Locus VNTR Analysis (MLVA) typing. The Polymerase Chain Reaction (PCR) is further classified into standard PCR, real time PCR, nested PCR, PCR based assays

On the basis of treatment market is segmented into antibiotics, vaccines, and others

On the basis of end-user, the market is segmented into hospitals & diagnostic centers, academic institutes, pharmaceutical & biotechnology companies and others.

 Regional Analysis:

Global brucellosis consists of regions namely the Americas, Europe, Asia Pacific, and the Middle East.

The European market dominated the global brucellosiss market owing to the high prevalence rate of this disease in the Eastern European regions. America holds the second largest share for the global brucellosiss market owing to the increasing research and development in biotechnology and pharmaceutical companies especially for study of genomics and diagnosis testing which play significant role in driving the global brucellosiss market.

Asia Pacific is expected to be the fastest growing region and is anticipated to compete with the American market. during the forecasted period 2017 to 2023. Brucellosis remains an uncontrolled problem in regions of high endemicity such as the Mediterranean, the Middle East, Africa, Latin America and parts of Asia. The presence of brucellosis in India was first established early in the previous century and since then has been reported from almost all states. Furthermore, brucellosis is the most common bacterial laboratory acquired infection worldwide.

Browse complete report at .

Key Players:

Some of key the players in the global brucellosiss market are Hester Biosciences Limited, ATA FEN Inc., Biogénesis-Bagó S.A., Biopharma, Biovet, Calier & Biologicos Laverlam, Merck Animal Health (MSD Animal Health), Colorado Serum Company, Indian Immunologicals Limited, Dollvet, Veterinary Technologies Corporation, China Animal Husbandry Co., Ltd. (CAHIC), LABIOFAM, BCG Vaccine Laboratory, and others.

Brucella are small aerobic intracellular organisms which localize in the reproductive organs of host animals, causing abortions and sterility. They usually spread through fliuds such as animal’s urine, milk, placental fluid, and others. To this day, 8 species have been identified, named primarily for the source animal or features of infection. Out of these, four species are significantly pathogenous to humans, these include Brucella melitensis (sheep, goats), Brucella suis (swine), Brucella abortus (buffalos, bison), Brucella canis (dogs)

In the U.S., the Nationwide eradication of brucellosis from domestic cattle and bison are carried out by governing bodies such as USDA, APHIS, Cooperative State Federal Program. Currently all 50 states as well as Puerto Rico and the U.S. Virgin Islands are brucellosis free. Any livestock market that has been approved by the State is handled under the supervision of the Cooperative State–Federal Brucellosis Eradication Program.

Ask Question to Expert at .

America is projected to hold the second largest share of the global brucellosis market as due to the eradication of these disease from the USA. Currently, fewer than 100 cases are reported annually to the Centers for Disease Control and Prevention (CDC) with approximately 60% of human brucellosis cases in the United States now occur in California and Texas. Brucellosis has become rare in North America due to numerous veterinary control measures such as routine screening and vaccination of domestic livestock. Most cases of brucella infection in the U.S. is due to the consumption of imported unpasteurized dairy products from Mexico.

The Asia Pacific and the Middle Eastern region is expected to grow at a faster rate due to the factors such as the extensive development of health care infrastructure and growing emphasis on research and development in the health care sector. The heaviest disease burden lies in countries of the Mediterranean basin and Arabian Peninsula, and the disease is also common in India, Mexico, and South & Central America. In Africa, incidence rates of 1.2-70 cases per 100,000 people have been reported. In Africa, such endemic diseases are controlled through animal slaughter due to the fragile nature of the food supply.


Market Research Future
Magarpatta Road, Hadapsar,
Pune – 411028
Maharashtra, India
+1 646 845 9312
Email: salesteam@Marketresearchfuture.Com

Leave a Reply

Your email address will not be published. Required fields are marked *